~ New contract strengthens Mobix Labs’ position as a trusted U.S. defense partner ~ ~ Expanding momentum driven by product sales and strategic acquisitions ~ IRVINE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (Nasdaq: MOBX), a fabless semiconductor company delivering next-generation connectivity solutions for defense, aerospace, 5G, and high-reliability markets, today announced it has won a multi-year follow-on production contract with a prime U.S. Navy contractor – a major step forward in t ...

ST. LOUIS, Mo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.4 billion for the three months ended September 30, 2025, compared with $1.2 billion a year ago. Net income available to common shareholders was $202.1 million, or $1.84 per diluted common share, compared with $149.2 million, or $1.34 per diluted common share for the third quarter of 2024. Non-GAAP net income available to common shareholders was $214.4 million, or $1.95 per diluted common sha ...

Core Insights - Winnebago Industries reported solid financial results for Q4 and full year Fiscal 2025, driven by a favorable product mix and targeted price increases, despite facing challenges in the operating environment [2][4][6] - The company achieved a net revenue of $777.3 million in Q4, marking a 7.8% increase from $720.9 million in Q4 Fiscal 2024 [6][11] - For the full year, net revenues totaled $2.8 billion, a decrease of 5.9% compared to $3.0 billion in Fiscal 2024, primarily due to a reduction in average selling price per unit [13][15] Financial Performance - Q4 gross profit was $99.2 million, with a gross margin of 12.8%, a slight decrease from 13.1% in Q4 Fiscal 2024 [7][8] - Net income for Q4 was $13.7 million, or $0.49 per diluted share, compared to a net loss of $29.1 million in the same quarter last year [11][12] - Adjusted EBITDA for Q4 increased by 33.1% year-over-year to $38.2 million [12] Operational Efficiency - Operating expenses decreased by 29.5% to $79.1 million in Q4, primarily due to prior year goodwill impairment and cost reduction initiatives [9][10] - The company reported a net cash flow from operations of $181.4 million in Q4, reflecting improved operational efficiency [26] Market Position and Share Expansion - Winnebago's brands, including Barletta and Grand Design RV, expanded their market share in key segments, particularly in the U.S. aluminum pontoon and motorhome markets [4][5] - The company showcased new products at the RV Open House, receiving positive feedback from dealers and customers [5] Balance Sheet Strength - Cash and cash equivalents at the end of Q4 totaled $174.0 million, a significant increase from $10.5 million at the end of Q3 [26] - The net leverage ratio improved to 3.1x at the end of Q4, down from 4.8x at the end of Q3 [26] Future Outlook - For Fiscal 2026, Winnebago anticipates consolidated net revenues in the range of $2.75 billion to $2.95 billion, with North American RV wholesale shipments expected between 315,000 to 345,000 units [28][32] - The company aims to strengthen margins and enhance operational efficiency while navigating the current competitive landscape [33]

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Aviva PLC (LSE: AV; OTCQX: AVVIY, AIVAF), the UK’s leading diversified insurer, has qualified to trade on the OTCQX® Best Market. Aviva PLC upgraded to OTCQX from the Pink Limited® Market. Aviva PLC begins trading today on OTCQX under the symbols “AVVIY” and “AIVAF.” U.S. investors can find current financial disclosure and Real- ...

COLMAR, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (NASDAQ:DORM) has released the aftermarket’s first-ever, all-new electronic power steering (EPS) rack engineered to fit more than two million Ram pickup trucks. The EPS rack is the culmination of a multi-year research, development, and commercialization effort executed by a cross-functional team across the enterprise. “Dorman’s unique capabilities allow us to design, engineer, test, and bring to market highly complex assemblies,” said Eric ...

Jericho, New York, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental-stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, has engaged Strategic Investor Relations, LLC, a premier investor relations firm, to enhance Curanex’s visibility in the financial community and support its ongoing efforts to engage and educate current and potential investors about the Company’s innovative p ...

DUNMORE, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank, announced its unaudited, consolidated financial results for the three- and nine-month periods ended September 30, 2025. Unaudited Financial Information Net income for the quarter ended September 30, 2025 was $7.3 million, or $1.27 per diluted share, compared to $5.0 million, or $0.86 per diluted share, for the quarter ended September 30, 2024. The $2 ...

Core Insights - Tonix Pharmaceuticals is conducting a pilot study named FOCUS to evaluate its investigational intranasal potentiated oxytocin products in patients with Arginine-Vasopressin Deficiency (AVP-D), a rare endocrine disorder linked to oxytocin deficiency and mental health issues [1][2] Group 1: Study Overview - The FOCUS study is a randomized, double-blind, placebo-controlled crossover trial aimed at generating preliminary data for future clinical studies on oxytocin replacement therapy in AVP-D [1][2] - The study will assess the effects of two different doses of investigational intranasal oxytocin products (6 IU, TNX-2900 and 24 IU, TNX-1900) on anxiety, depression, and socioemotional functioning in patients with AVP-D [2] Group 2: Product Information - TNX-1900 and TNX-2900 are based on Tonix's patented intranasal magnesium-potentiated oxytocin formulations, designed to enhance oxytocin receptor binding and its effects on trigeminal neurons [3] - TNX-1900 is being developed for chronic migraine prevention, while TNX-2900 targets Prader-Willi syndrome in children and adolescents [3] Group 3: Company Background - Tonix Pharmaceuticals is a fully integrated biotechnology company with a focus on central nervous system disorders, immunology, and rare diseases, among other areas [10] - The company has received FDA approval for Tonmya™, a non-opioid analgesic for fibromyalgia, marking the first new prescription medicine approval for this condition in over 15 years [10]

LONG ISLAND CITY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its third quarter 2025 earnings results on Wednesday, November 5, 2025. Management will host a conference call to review the results at 8:30 a.m. Eastern Time. The live webcast of the management call can be accessed at the Company’s investor relations website at https://investor.st ...

Core Insights - Brightstar Lottery PLC has signed a five-year exclusive licensing agreement with Avanti Licensing, Inc. to develop and distribute omnichannel lottery games based on Avanti's humorous greeting cards [1] - The partnership aims to leverage Avanti's extensive image library and Brightstar's game design expertise to create engaging lottery experiences [1] Company Overview - Brightstar Lottery PLC (NYSE: BRSL) is a global leader in the lottery industry, known for its secure technology and comprehensive solutions [3] - The company employs approximately 6,000 people and is recognized for its integrity and responsibility in lottery operations [3] Partnership Details - Avanti Licensing, Inc. is known for its character-driven greeting cards and has a global presence, with products translated into over 12 languages [1] - The collaboration will focus on creating instant tickets, innovative draw-based games, and engaging eInstant games that reflect Avanti's trademark humor [1]